Correlation Between Ligand Pharmaceuticals and Design Therapeutics

Can any of the company-specific risk be diversified away by investing in both Ligand Pharmaceuticals and Design Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ligand Pharmaceuticals and Design Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ligand Pharmaceuticals Incorporated and Design Therapeutics, you can compare the effects of market volatilities on Ligand Pharmaceuticals and Design Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ligand Pharmaceuticals with a short position of Design Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ligand Pharmaceuticals and Design Therapeutics.

Diversification Opportunities for Ligand Pharmaceuticals and Design Therapeutics

0.65

Correlation Coefficient

Ligand Pharmaceuticals  Design Therapeutics

Poor diversification

The 3 months correlation between Ligand and Design is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Ligand Pharmaceuticals Incorpo and Design Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Design Therapeutics and Ligand Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ligand Pharmaceuticals Incorporated are associated (or correlated) with Design Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Design Therapeutics has no effect on the direction of Ligand Pharmaceuticals i.e., Ligand Pharmaceuticals and Design Therapeutics go up and down completely randomly.

Pair Corralation between Ligand Pharmaceuticals and Design Therapeutics

Given the investment horizon of 90 days Ligand Pharmaceuticals is expected to generate 1.64 times less return on investment than Design Therapeutics. But when comparing it to its historical volatility, Ligand Pharmaceuticals Incorporated is 2.13 times less risky than Design Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Design Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  473.00  in Design Therapeutics on September 1, 2024 and sell it today you would earn a total of  127.00  from holding Design Therapeutics or generate 26.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Ligand Pharmaceuticals Incorpo  vs.  Design Therapeutics

Ligand Pharmaceuticals

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Ligand Pharmaceuticals Incorporated are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Ligand Pharmaceuticals exhibited solid returns over the last few months and may actually be approaching a breakup point.

Design Therapeutics

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Design Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady technical and fundamental indicators, Design Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Ligand Pharmaceuticals and Design Therapeutics

The main advantage of trading using opposite Ligand Pharmaceuticals and Design Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ligand Pharmaceuticals position performs unexpectedly, Design Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will offset losses from the drop in Design Therapeutics' long position.

The idea behind Ligand Pharmaceuticals Incorporated and Design Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.